SPRY4
From Wikipedia, the free encyclopedia
Sprouty homolog 4 (Drosophila)
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | SPRY4; | |||||||||||||
External IDs | OMIM: 607984 MGI: 1345144 HomoloGene: 8042 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 81848 | 24066 | ||||||||||||
Ensembl | ENSG00000187678 | ENSMUSG00000024427 | ||||||||||||
Uniprot | Q9C004 | Q543R1 | ||||||||||||
Refseq | NM_030964 (mRNA) NP_112226 (protein) |
XM_988191 (mRNA) XP_993285 (protein) |
||||||||||||
Location | Chr 5: 141.67 - 141.68 Mb | Chr 18: 38.71 - 38.73 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Sprouty homolog 4 (Drosophila), also known as SPRY4, is a human gene.[1]
SPRY4 is an inhibitor of the receptor-transduced mitogen-activated protein kinase (MAPK) signaling pathway. It is positioned upstream of RAS (see HRAS; MIM 190020) activation and impairs the formation of active GTP-RAS (Leeksma et al., 2002).[supplied by OMIM][1]
[edit] References
[edit] Further reading
- Zaharieva I, Georgieva L, Nikolov I, et al.. "Association study in the 5q31-32 linkage region for schizophrenia using pooled DNA genotyping.". BMC psychiatry 8: 11. doi: . PMID 18298822.
- Cabrita MA, Jäggi F, Widjaja SP, Christofori G (2006). "A functional interaction between sprouty proteins and caveolin-1.". J. Biol. Chem. 281 (39): 29201-2912. doi: . PMID 16877379.
- Katoh Y, Katoh M (2006). "FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of WNT signaling pathway in progenitor cells.". Int. J. Mol. Med. 17 (3): 529-32. PMID 16465403.
- Wang J, Thompson B, Ren C, et al. (2006). "Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.". Prostate 66 (6): 613-24. doi: . PMID 16388505.
- Ding W, Bellusci S, Shi W, Warburton D (2004). "Genomic structure and promoter characterization of the human Sprouty4 gene, a novel regulator of lung morphogenesis.". Am. J. Physiol. Lung Cell Mol. Physiol. 287 (1): L52-9. doi: . PMID 14977631.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi: . PMID 14702039.
- Sasaki A, Taketomi T, Kato R, et al. (2003). "Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.". Nat. Cell Biol. 5 (5): 427-32. doi: . PMID 12717443.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Leeksma OC, Van Achterberg TA, Tsumura Y, et al. (2002). "Human sprouty 4, a new ras antagonist on 5q31, interacts with the dual specificity kinase TESK1.". Eur. J. Biochem. 269 (10): 2546-56. PMID 12027893.